Human PD-L2/B7-DC PicoKine ELISA Kit

Human PD-L2/B7-DC PicoKine ELISA Kit 

To Order Contact us: [email protected]

Human CellExp? PD-L2 / B7-DC, mouse recombinant
P1087-10	Biovision		EUR 170.4

Human CellExp? PD-L2 / B7-DC, mouse recombinant
P1087-50	Biovision		EUR 548.4

Recombinant Human B7-DC/PD-L2/CD273 Protein
RP00988	Abclonal	10 μg	EUR 186

Recombinant Human B7-DC/PD-L2/CD273 Protein
RP00150	Abclonal	20 μg	EUR 231.6

Human CellExp? CD273 / B7-DC / PD-L2, human recombinant
7369-10	Biovision		EUR 294

Human CellExp? CD273 / B7-DC / PD-L2, human recombinant
7369-50	Biovision		EUR 836.4

Recombinant Mouse PD-L2/B7-DC/CD273 Protein
RP00660	Abclonal	10 μg	EUR 174

Recombinant Human PD-L2/B7-DC/CD273 (C-mFC)
CW20-10ug	Novoprotein	10ug	EUR 175.2
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human PD-L2/B7-DC/CD273 (C-mFC)
CW20-1mg	Novoprotein	1mg	EUR 2739.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human PD-L2/B7-DC/CD273 (C-mFC)
CW20-500ug	Novoprotein	500ug	EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human PD-L2/B7-DC/CD273 (C-mFC)
CW20-50ug	Novoprotein	50ug	EUR 363.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human PD-L2/B7-DC/CD273 (C-6His)
CA09-10ug	Novoprotein	10ug	EUR 242.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human PD-L2/B7-DC/CD273 (C-6His)
CA09-1mg	Novoprotein	1mg	EUR 2739.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human PD-L2/B7-DC/CD273 (C-6His)
CA09-500ug	Novoprotein	500ug	EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human PD-L2/B7-DC/CD273 (C-6His)
CA09-50ug	Novoprotein	50ug	EUR 595.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc)
CJ99-10ug	Novoprotein	10ug	EUR 120
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc)
CJ99-1mg	Novoprotein	1mg	EUR 814.8
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc)
CJ99-500ug	Novoprotein	500ug	EUR 589.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc)
CJ99-50ug	Novoprotein	50ug	EUR 230.4
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Rat Anti-Mouse PD-L2 (B7-DC) Monoclonal antibody, clone TY25
CABT-L4293-1mg	Creative Diagnostics	1 mg	EUR 1076.4

Rat Anti-Mouse PD-L2 (B7-DC) Monoclonal antibody, clone TY25
CABT-L4293-5mg	Creative Diagnostics	5 mg	EUR 2886

Human PD-L1/B7-H1 PicoKine ELISA Kit
EK1449	BosterBio	96 wells	EUR 510
Description: For quantitative detection of human PD-L1 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA).

Mouse PD-L1/B7-H1 PicoKine ELISA Kit
EK1450	BosterBio	96 wells	EUR 510
Description: For quantitative detection of mouse PD-L1 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA).

anti-B7 DC
YF-PA21096	Abfrontier	100 ug	EUR 483.6
Description: Rabbit polyclonal to B7 DC

Human PD-1 PicoKine ELISA Kit
EK0959	BosterBio	96 wells	EUR 546
Description: For quantitative detection of human PD-1 in cell culture supernates, serum and plasma(heparin).

PD-L2 Antibody
4063-002mg	ProSci	0.02 mg	EUR 206.18
Description: PD-L2 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by co gnate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2, both of which are thought act as a negative regulator of T cell activation. However, it has been suggested that PD-L2 can act to stimulate an immunogenic response through and alternative receptor from PD-1.

PD-L2 Antibody
4063-01mg	ProSci	0.1 mg	EUR 523.7
Description: PD-L2 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by co gnate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2, both of which are thought act as a negative regulator of T cell activation. However, it has been suggested that PD-L2 can act to stimulate an immunogenic response through and alternative receptor from PD-1.

PD-L2 Peptide
4063P	ProSci	0.05 mg	EUR 197.7
Description: (IN) PD-L2 peptide

Human B7-1/CD80 PicoKine ELISA Kit
EK0707	BosterBio	96 wells	EUR 510
Description: For quantitative detection of human CD80 in cell culture supernates and serum.

Polyclonal Anti-B7-DC antibody
APR05481G	Leading Biology	0.1ml	EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Anti-B7-DC . This antibody is tested and proven to work in the following applications:

Anti-B7 DC/PDCD1LG2 Antibody
PB10010	BosterBio	100ug/vial	EUR 352.8

PD-L2 Recombinant Protein
91-721	ProSci	0.05 mg	EUR 821.4
Description: Programmed Cell Death 1 Ligand 2 (PDCD1LG2) is a member of the BTN/MOG family. PDCD1LG2 contains one Ig-like C2-type domain and one Ig-like V-type domain. PDCD1LG2 is highly expressed in the heart, placenta, pancreas, lung and liver; it is weakly expressed in the spleen, lymph nodes, and thymus. PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PDCD1LG2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.

PD-L2 Recombinant Protein
92-497	ProSci	0.05 mg	EUR 437.1
Description: Programmed cell death 1 ligand 2 (PD-L2), also known as butyrophilin B7-DC or PDCD1 ligand 2, belongs to the member of B7 family which can regulate the activation and tolerance of T cells. PD-L2 is one ligand for Programmed cell death 1(PD-1), and the other is PD-L1. These two ligands shares 34% aa sequence identity. Mouse PD-L2 gene encodes a 273 amino acids (aa) protein with a putative 19 aa signal peptide, a 201 aa extracellular region , a 21 aa transmembrane domain and a 32 aa cytoplasmic region. The mouse PD-L2 gene is highly expressed in heart, placenta, pancreas, lung and liver while expressed weakly in spleen, lymph nodes and thymus. Besides, the expression of PD-L2 gene can be induced on dendritic cells grown from peripheral blood mononuclear cells under CSF2 and IL4/interleukin-4 treatment, and up-regulated by IFNG/IFN-gamma stimulation in monocytes. PD-L2 usually functions in a PDCD1-independent manner and is involved in regulating costimulatory signal which is essential for T-cell proliferation and IFNG production. Recent studies demonstrate that the expression of PD-L2 on the tumor cells promotes CD8 T cell–mediated rejection of tumor cells, at both the induction and effector phase of antitumor immunity. Moreover, PD-L2 binds to PD-1 cells and enhances T cell killing in a PD-1–independent mechanism.

PD-L2 Polyclonal Antibody
ABP59870-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of PD-L2 from Human. This PD-L2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human PD-L2 protein at amino acid sequence of 31-80

PD-L2 Polyclonal Antibody
ABP59870-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of PD-L2 from Human. This PD-L2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human PD-L2 protein at amino acid sequence of 31-80

PD-L2 Polyclonal Antibody
ABP59870-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of PD-L2 from Human. This PD-L2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human PD-L2 protein at amino acid sequence of 31-80

PD-L2 Recombinant Protein
96-938	ProSci	0.1 mg	EUR 651.3
Description: Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.

PD-L2 Recombinant Protein
97-021	ProSci	0.1 mg	EUR 651.3
Description: Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.

PD-L2 Recombinant Protein
97-022	ProSci	0.1 mg	EUR 651.3
Description: Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.

PD-L2 Polyclonal Antibody
ES8685-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against PD-L2 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

PD-L2 Polyclonal Antibody
ES8685-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against PD-L2 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

Anti-PD-L2 antibody
STJ98748	St John's Laboratory	200 µl	EUR 236.4
Description: Rabbit polyclonal to PD-L2.

ELISA kit for Human PD-L1/B7-H1
EK5678	SAB	96 tests	EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human PD-L1/B7-H1 in samples from serum, plasma, tissue homogenates and other biological fluids.

QuickDetect? PD-L1/B7-H1 (Human) ELISA Kit
K4416-100	Biovision		EUR 1096.8

B7-H1/PD-L1
E21-315	EnoGene	10ug	EUR 411.6

Mouse B7-1/CD80 PicoKine ELISA Kit
EK0708	BosterBio	96 wells	EUR 547.2
Description: For quantitative detection of mouse CD80 in cell culture supernates and serum.

Rat CD80/B7-1 PicoKine ELISA Kit
EK0709	BosterBio	96 wells	EUR 510
Description: For quantitative detection of rat CD80 in cell culture supernates and serum.

Mouse CD86/B7-2 PicoKine ELISA Kit
EK0711	BosterBio	96 wells	EUR 510
Description: For quantitative detection of mouse CD86 in cell culture supernates and serum.

Rat CD86/B7-2 PicoKine ELISA Kit
EK0712	BosterBio	96 wells	EUR 510
Description: For quantitative detection of rat CD86 in cell culture supernates and serum.

ELISA kit for Mouse PD-L1/B7-H1
EK5679	SAB	96 tests	EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse PD-L1/B7-H1 in samples from serum, plasma, tissue homogenates and other biological fluids.

CD273 [PD-L2] Recombinant Protein
90-425	ProSci	100 ug	EUR 651.3
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals.

CD273 [PD-L2] Recombinant Protein
90-427	ProSci	100 ug	EUR 651.3
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals.

CD273 [PD-L2] Recombinant Protein
90-428	ProSci	100 ug	EUR 651.3
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals.

Human B7-1/CD80 PicoKine™ Fast ELISA Kit
FEK0707	BosterBio	96 wells	EUR 570
Description: The Fast version of Picokine ELISA kits, assay takes less than 1.5 hours. Detect Human B7-1/CD80 with <10pg/ml sensitivity. Format: 96-well plate with removable strips. Compatible samples: cell culture supernates and serum. This is a TMB colorimetric sandwich ELISA kit with short assay time and fast experiment set up. B7-1/CD80 tissue specificity: Expressed on activated B-cells, macrophages and dendritic cells.

Ribosome-inactivating protein PD-L1 / PD-L2 Antibody
20-abx319445	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Ribosome-inactivating protein PD-L1/PD-L2 Antibody
1-CSB-PA306294LA01PJJ	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is Unconjugated. Tested in the following application: ELISA

PD-L1/B7-H1/CD274
E21-J88	EnoGene	10ug	EUR 411.6

Mouse Anti-Human CD273 (PD-L2) mAb
CM031-100ug	SAB	100ug	EUR 250.8

Mouse Anti-Human CD273 (PD-L2) mAb
CM031-25ug	SAB	25ug	EUR 154.8

PD-L2, Fc Chimera (HEK293-expressed), Human
HY-P7399	MedChemExpress	50ug	EUR 321.6

TranslationBlocker Human PD-L2/ CD273 siRNA, 10nmol
QX8-10nmol	EnQuireBio	10nmol	EUR 452.4

TranslationBlocker Human PD-L2/ CD273 siRNA, 2nmol
QX8-2nmol	EnQuireBio	2nmol	EUR 331.2

Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (HRP)
20-abx319446	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (FITC)
20-abx319447	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (Biotin)
20-abx319448	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Phytolacca dioica Ribosome-inactivating protein PD-L1/PD-L2
1-CSB-EP306294PJJ	Cusabio	EUR 733.20 EUR 370.80 EUR 2192.40 EUR 1126.80 EUR 1461.60 EUR 476.40	100ug 10ug 1MG 200ug 500ug 50ug
Description: Recombinant Phytolacca dioica Ribosome-inactivating protein PD-L1/PD-L2 expressed in E.coli

Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody
A64216-020	EpiGentek	20 ul	EUR 117.7

Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody
A64216-050	EpiGentek	50 ul	EUR 302.5

Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody
A64216-100	EpiGentek	100 ul	EUR 423.5

Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody
A64216	EpiGentek	EUR 684.66 EUR 117.70 EUR 302.50 EUR 423.50	100 µg 20 ul 50 ul 100 ul

Recombinant Human PD-L1/B7-H1 Protein
RP00068	Abclonal	5 μg	EUR 163.2

Recombinant Human PD-L1/B7-H1 Protein
RP00184	Abclonal	10 μg	EUR 178.8

PD-L1 / B7-H1 Recombinant Protein
11-345	ProSci	0.1 mg	EUR 714.3
Description: Programmed cell death 1 ligand 1 (PDL1) is also known as B7-H, B7H1, MGC142294, MGC142296, PD-L1, PDCD1L1 and PDCD1LG1,which is a member of the growing B7 family of immune molecules and is involved in the regulation of cellular and humoral immune responses.PDL1 is a cell surface immunoglobulin superfamily with two Ig-like domains within the extracellular region and a short cytoplasmic domain. This protein is broadly expressed in the majority of peripheral tissues as well as hematopoietic cells. Interaction between PDL1 and its receptors belonging to the CD28 family of molecules provide both stimulatory and inhibitory signals in regulating T cell activation and tolerance. PDL1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression.

PD-L1 Antibody / B7-H1 / CD274
F55054-0.1ML	NSJ Bioreagents	0.1ml	EUR 399

PD-L1 Antibody / B7-H1 / CD274
R32479	NSJ Bioreagents	100 ug	EUR 419

PD-L1 Antibody / B7-H1 / CD274
R32579	NSJ Bioreagents	100 ug	EUR 419

PD-L1 Antibody / B7-H1 / CD274
V8598-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V8598-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V8598SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V8640-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V8640-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V8640SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V8641-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancers ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V8641-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancers ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V8641SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancers ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V9155-100UG	NSJ Bioreagents	100ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells.

PD-L1 Antibody / B7-H1 / CD274
V9155-20UG	NSJ Bioreagents	20ug	EUR 219
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells.

PD-L1 Antibody / B7-H1 / CD274
V9155SAF-100UG	NSJ Bioreagents	100ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells.

PD-L1 Antibody / B7-H1 / CD274
V3955-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. recruitment of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. Constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

PD-L1 Antibody / B7-H1 / CD274
V3955-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. recruitment of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. Constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

PD-L1 Antibody / B7-H1 / CD274
V3955BTN	NSJ Bioreagents	500 ul	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V3955PE-100T	NSJ Bioreagents	100 Tests	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V3955SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. recruitment of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. Constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

PD-L1 Antibody / B7-H1 / CD274
V7822-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V7822-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V7822SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V7823-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V7823-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V7823SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V7974-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V7974-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V7974SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V7988-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. Engagement of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

PD-L1 Antibody / B7-H1 / CD274
V7988-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. Engagement of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

PD-L1 Antibody / B7-H1 / CD274
V7988SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. Engagement of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

PD-L1 Antibody / B7-H1 / CD274
V8009-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V8009-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

PD-L1 Antibody / B7-H1 / CD274
V8009SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

Human PD-L2/B7-DC PicoKine ELISA Kit